SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nuo Therapeutics, Inc.  
 TX


        

Filings Subset of Filing/Form Type  8-K:  Current Reports — Form 8-K with Item 5.02 or 6:  Governance & Management – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers   ·   List all 1,094 Filings, not just this Subset
Filing emoji

38  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
-Q to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
  1/3/19  Nuo Therapeutics, Inc.            8-K:5      12/31/18    1:24K                                    RDG Filings/FA           
 8/10/18  Nuo Therapeutics, Inc.            8-K:4,5,9    8/9/18    2:42K                                    RDG Filings/FA           
 6/28/18  Nuo Therapeutics, Inc.            8-K:5       6/25/18    1:18K                                    RDG Filings/FA           
 1/19/18  Nuo Therapeutics, Inc.            8-K:5,8     1/12/18    1:22K                                    RDG Filings/FA           
 4/10/17  Nuo Therapeutics, Inc.            8-K:5,9      4/6/17    2:33K                                    RDG Filings/FA           
  7/8/16  Nuo Therapeutics, Inc.            8-K:5,8      7/1/16    1:30K                                    Toppan Merrill/FA        
 5/10/16  Nuo Therapeutics, Inc.            8-K:1,3,5,9  5/5/16    6:366K                                   Toppan Merrill/FA        
 1/12/16  Nuo Therapeutics, Inc.            8-K:5       1/12/16    1:14K                                    Toppan Merrill/FA        
 1/12/16  Nuo Therapeutics, Inc.            8-K:2,5,8,9  1/8/16    2:39K                                    Toppan Merrill/FA        
 7/15/15  Nuo Therapeutics, Inc.            8-K:5        7/9/15    1:14K                                    Toppan Merrill/FA        
 4/30/15  Nuo Therapeutics, Inc.            8-K:5,9     4/24/15    2:37K                                    Toppan Merrill/FA        
12/31/14  Nuo Therapeutics, Inc.            8-K:5      12/29/14    1:15K                                    Toppan Merrill/FA        
 7/18/14  Nuo Therapeutics, Inc.            8-K/A:5,9    6/9/14    5:43K                                    Toppan Merrill/FA        
 6/13/14 Nuo Therapeutics, Inc.            8-K:5,9      6/9/14    2:30K                                    Toppan Merrill/FA        
 5/30/14  Nuo Therapeutics, Inc.            8-K:1,5,9   5/23/14    4:284K                                   Toppan Merrill/FA        
 4/11/14  Nuo Therapeutics, Inc.            8-K:5,9      4/8/14    1:19K                                    Toppan Merrill/FA        
10/31/13  Nuo Therapeutics, Inc.            8-K:5,9    10/28/13    1:14K                                    Toppan Merrill/FA        
  4/3/13  Nuo Therapeutics, Inc.            8-K:1,5,8,9 3/29/13    2:47K                                    Toppan Merrill/FA        
 3/15/13  Nuo Therapeutics, Inc.            8-K:1,5,9   3/12/13    1:17K                                    Toppan Merrill/FA        
 6/13/12  Nuo Therapeutics, Inc.            8-K:5        6/7/12    1:15K                                    Toppan Merrill/FA        
____________
 ‡  A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm
Five-thirty emoji
ET
.  The legal “Filed As Of” date may be the next, or another, day.
 ¹  Filing/Form Type: 
Type emoji
/A
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  /A  Amendment to, or Amended version of, a previous Filing of this Type.
 
Page:  
Page 1 emoji
  2   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 2:58:58.8am ET